Showing results (291-300 of 500) with videos related to
Sort By:
Pageof 50
JACC. Advances|June 28, 2024
Advances in the Staging and Phenotyping of Cardiogenic Shock: Part 1 of 2Jacob C Jentzer, Corbin Rayfield, Sabri Soussi, et al.JAMA Cardiology|March 5, 2020
Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.Circulation Research|October 26, 2018
A Path Forward for Regenerative MedicineAlexander C Fanaroff, Valarie Morrow, Mitchell W Krucoff, et al.Circulation Research|July 8, 2015
A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart FailureEmerson C Perin, Kenneth M Borow, Guilherme V Silva, et al.Journal of the American College of Cardiology|April 25, 2020
Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP)Ehtisham Mahmud, Harold L Dauerman, Frederick G P Welt, et al.Circulation. Cardiovascular Interventions|May 31, 2015
Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy studyTracy Y Wang, Timothy D Henry, Mark B Effron, et al.JAMA Cardiology|November 14, 2019
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.JACC. Cardiovascular Interventions|September 22, 2018
Delays in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic ShockAjar Kochar, Hussein R Al-Khalidi, Steen M Hansen, et al.American Heart Journal|June 15, 2016
Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarctionJacob A Doll, Tracy Y Wang, Niteesh K Choudhry, et al.Journal of the American College of Cardiology|July 10, 2007
Thrombosis and drug-eluting stents: an objective appraisalDavid R Holmes, Dean J Kereiakes, Warren K Laskey, et al.Pageof 50